Canada Markets close in 4 hrs 35 mins

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
225.40-1.52 (-0.67%)
As of 11:25AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close226.92
Bid224.48 x 800
Ask224.94 x 800
Day's Range223.00 - 230.00
52 Week Range76.59 - 331.68
Avg. Volume4,901,521
Market Cap16.701B
Beta (5Y Monthly)1.55
PE Ratio (TTM)N/A
EPS (TTM)-9.51
Earnings DateMay 10, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est264.20
  • Editor's Pick
    Yahoo Finance Video

    Doctor reacts to U.S. travel ban changes

    Baylor College of Medicine Assistant Professor Dr. Sara Andrabi joins Yahoo Finance to discuss the requirement of vaccinations for foreign travelers and other trends amid the COVID-19 pandemic. 

  • Motley Fool

    I'm Sitting On a Record Amount of Cash: Here Are 5 Stocks I'm Looking to Buy

    If you buy high-quality companies and hang onto them for long periods of time, your chances of growing your initial investment by leaps and bounds goes up significantly. What's more, Novavax's vaccine development platform should allow it to quickly tackle new variants and develop potential combination treatments in the future.

  • CNW Group

    Novavax to Participate in Fireside Chat at Devex @ UNGA 76

    Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing and commercializing next-generation vaccines for serious infectious diseases, today announced that John J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Business Officer, will be interviewed at Devex @ UNGA 76 on September 21 at 8:50 a.m. The event is hosted by the media outlet Devex and is taking place September 21-23 via livestream as part of its coverage of the 76th meeting of the United Nations General